⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BMY News
Bristol-Myers Squibb Co.
Global Orphan Drugs Market Size, Share and Trends Analysis Report, 2026-2033 | Market to Reach USD 434.9 Billion as Gene and Cell Therapies Drive 9.0% CAGR
globenewswire.com
JNJ
AZN
NVS
VRTX
SNY
AMGN
MRK
BMY
PFE
Intelligent Power Module Market Size, Share, and Trends - Global Forecast 2026-2032 | EVs, Renewables, and AI Infrastructure Fuel 10.26% CAGR and a USD 5.93 Billion Market by 2032
globenewswire.com
ON
MPWR
POWI
NXPI
ADI
TXN
NVDA
AMD
INTC
MU
AMAT
LRCX
KLAC
WOLF
AEHR
QCOM
MRVL
ADSK
MSFT
GOOGL
AMZN
TSLA
GM
F
NIO
LI
XPEV
PLUG
FCEL
ENPH
SEDG
CRSR
ROKU
SONY
PANW
CSCO
IBM
ACGL
VSH
DIOD
LFUS
MCHP
AEIS
NVTS
AOSL
SWKS
TER
AMGN
GILD
BMY
MRNA
PFE
BIIB
REGN
VRTX
ALGN
ISRG
High-Temperature Superconductor Wires Market - Global Forecast 2026-2032 | Grid Modernization and Fusion Demand Drive 9.83% CAGR to USD 1.68 Billion by 2032
globenewswire.com
AMSC
GE
BRK.A
IBM
AMAT
NVDA
GOOG
MSFT
INTC
AMD
MU
TER
ADI
TXN
ON
NXPI
QCOM
MRVL
SNPS
CDNS
LRCX
KLAC
ASML
PLAB
AMGN
GILD
BMY
PFE
MRK
JNJ
BIIB
REGN
VRTX
MDLZ
BA
LMT
RTX
GD
HII
XOM
CVX
NEE
DUK
SO
AEP
ED
PCG
SRE
XEL
WEC
ETR
NI
D
CMS
PNW
ES
CEG
EXC
EIX
NRG
BWXT
SPWR
FSLR
ENPH
SEDG
PLUG
BALL
AMZN
GOOGL
ROK
HON
ETN
CPRI
V
MA
PYPL
AVGO
CRSP
EDIT
NTLA
ALGN
ISRG
TDOC
BABA
JD
NTES
SMCI
DELL
HPQ
CSCO
Izalontamab Brengitecan (Iza-Bren) Doubles Median Progression-Free Survival in Patients with Previously-Treated EGFR-Mutated Non-Small Cell Lung Cancer Compared to Chemotherapy in the Phase 3 PANKU-Lung01 Study
businesswire.com
BMY
BioNTech and Bristol Myers Squibb Report Encouraging Global Phase 2 Data for Pumitamig in Advanced NSCLC After Progression on Immunotherapy Plus Chemotherapy
globenewswire.com
BNTX
BMY
The Lanier Law Firm Supports Attorney General Ken Paxton in Reaching $45 Million Settlement with Gilead in Unlawful Inducement Scheme
businesswire.com
GILD
BMY
NVS
LLY
Immune Checkpoint Inhibitors Market Size, Share, Trends, and Global Forecast to 2030 | Next-Generation Targets and Combination Therapies Create New Growth Opportunities
globenewswire.com
BMY
GSK
INCY
NVS
JNJ
SNY
EXR
Izalontamab Brengitecan (Iza-Bren) Reduced Risk of Disease Progression or Death by 59% versus Chemotherapy in Patients with Advanced HR+/HER2- Breast Cancer in Phase 3 PANKU-Breast01 Study
businesswire.com
BMY
Enterome Phase 1/2 data show OncoMimics™ EO4010-induced CD8 T-cell expansion was associated with longer survival in patients with colorectal cancer
globenewswire.com
BMY
Chinese AI Quietly Writes Hackable Code for Beijing's Adversaries, Even When Run Locally, Study Finds
businesswire.com
BABA
CRWD
BAH
AI
NVDA
MSFT
GOOG
AMZN
IBM
META
INTC
AMD
QCOM
MU
SMCI
PLTR
DDOG
SNOW
PANW
FTNT
ZS
CHKP
VRTX
GILD
AMGN
REGN
BMY
PFE
MRNA
TSLA
RIVN
LCID
NIO
XPEV
CCJ
UROY
MARA
RIOT
TCOM